Study to Evaluate GR1801's Efficacy and Safety

NCT05846568 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1200

Enrollment

INDUSTRY

Sponsor class

Conditions

Rabies Post-exposure Prophylaxis

Interventions

BIOLOGICAL: GR1801
BIOLOGICAL: Human Rabies Immunoglobulin(HRIG)
BIOLOGICAL: Rabies Vaccine

Sponsor

Genrix (Shanghai) Biopharmaceutical Co., Ltd.